Skip to search formSkip to main contentSkip to account menu

cationic amphipathic peptide KT2

Known as: KT2 cationic amphipathic peptide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The emergence of multi-drug resistant bacteria forces the therapeutic world into a position, where the development of new and… 
Highly Cited
2014
Highly Cited
2014
Cationic, amphipathic host defense peptides represent a promising group of agents to be developed for anticancer applications… 
2014
2014
Tethered bilayer lipid membranes (tBLMs) on solid supports have substantial advantages as models of artificial cell membranes for… 
2000
2000
The present study was designed to assess the protective effect of a selective thromboxane A₂ receptor antagonist, KT2-962 (KT2… 
Highly Cited
1996
Highly Cited
1996
Xenobiotic amphipathic carboxylates, known collectively as hypolipidemic peroxisome proliferators (e.g., aryloxyalkanoic acids… 
Highly Cited
1991
Highly Cited
1991
The effect in mice of the molecular weight of polyethyleneglycol on prolonging the circulation time of large unilamellar…